Advertisement

Mediterranean Journal of Nutrition and Metabolism

, Volume 2, Issue 2, pp 127–131 | Cite as

Improvement of antioxidant status in women conventionally treated for breast cancer after 12 months of a cow milk whey-based supplementation. A preliminary study

  • G. Landoni
  • E. Mariani
  • G. Oriani
  • C. Donarini
  • T. Guerrerio
  • E.L. Iorio
Original Article

Abstract

Background

Cancer chemo- and radiotherapy are constantly associated with unwanted side effects at least partially ascribable to oxidative stress, an imbalance between pro-oxidant and antioxidant factors. However, the possible indication and efficacy of antioxidant supplementations — including glutathione-based formulas — aimed to restore the oxidative balance should be, respectively, evaluated and monitored carefully with reliable analytical tools.

Aim

Because previous studies on cystic fibrosis and athletes showed that high-cysteine-content, whey-based formulas were able to improve glutathione levels in cystic fibrosis and in healthy exercising people, the aim of this preliminary study was to evaluate the impact on oxidative balance of a new antioxidant supplementation, based on a high-cysteine formula containing a protein mimicking breast milk, on women conventionally treated for breast cancer.

Subjects and methods

Twenty women suffering from breast cancer under ambulatory conventional antineo-plastic treatment were supplemented for 12 consecutive months with 10 g u.i.d. of an oral nutraceutical lipid- and lactose-free formula containing a mix of peptides from cow’s milk whey having a high content of cysteine and glutamic acid as the main biochemical precursor of glutathione (Prother®, DMF Limbiate, MI, Italy). During the study period the recruited subjects underwent a periodical (bimonthly) clinical visit, during which they were tested for oxidative balance (BAP test and d-ROMs). Before and at the end of the study the women were invited to complete the Spitzer Questionnaire.

Results

Plasma antioxidant capacity, as detected by the BAP test, showed a marked early trend towards a progressive increase, reaching statistical significance at the end of the treatment (2319.5 ± 288.7 vs. 1894.5 ± 362.5 μmol/l reduced iron, respectively; p = 0.007). Plasma oxidant status, as measured by means of the d-ROMs test, after an irregular time-course, increased significantly at the 12th month, compared to the baseline value (350.29 ± 39.29 vs. 407.00 ± 58.54 CARR U, respectively; p = 0.0017). The treatment was well tolerated.

Discussion

The breast milk-mimicking protein formula intake was associated with a restoration of biological antioxidant potential, maybe by increasing the bioavailability of antioxidant components, and reduced glutathione, with no apparent interference with the intrinsic pharmacological/chemical mechanism (oxidant species generation) of the current treatment (chemo/radiotherapy).

Conclusions

This preliminary study indicates that 12 months of regular oral intake of a high-content cysteine nutraceutic formula is associated with increased plasma antioxidant capacity in women conventionally treated for breast cancer. Moreover, the data from oxidative status assessment suggest that the above supplement did not interfere with oxidant production, the increase of which is related to the cancer and antineoplastic treatment itself. Finally, the d-ROMs and BAP tests were shown to be very reliable tools to monitor ambulatory oxidative balance in this kind of patient.

Keywords

Oxidative stress Antioxidants d-ROMs test BAP test Whey proteins 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kang DH (2002) Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 13:540–549CrossRefGoogle Scholar
  2. 2.
    Halliwell B, Gutteridge JMC (1999) Free radicals in biology and medicine, 3rd Edn. Clarendon Press, OxfordGoogle Scholar
  3. 3.
    Juránek I, Bezek S (2005) Controversy of free radical hypothesis: reactive oxygen species — cause or consequence of tissue injury? Gen Physiol Biophys 24:263–278Google Scholar
  4. 4.
    Beinert T, Binder D, Stuschke M et al (1999) Oxidant-induced lung injury in anticancer therapy. Eur J Med Res 4:43–53Google Scholar
  5. 5.
    Lee MK, Son BH, Hwang SY et al (2007) Factors affecting health-related quality of life in women with recurrent breast cancer in Korea. Qual Life Res 16:559–569CrossRefGoogle Scholar
  6. 6.
    Simone CB 2nd, Simone NL, Simone V, Simone CB (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med 13:22–28Google Scholar
  7. 7.
    Mantovani G, Macciò A, Madeddu C et al (2002) Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J Cell Mol Med 6:570–582CrossRefGoogle Scholar
  8. 8.
    Dohi K, Satoh K, Ohtaki H et al (2005) Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging. In Vivo 19:855–860Google Scholar
  9. 9.
    Alberti A, Bolognini L, Macciantelli D, Carratelli M (2000) The radical cation of N,N-diethyl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples. Res Chem Intermed 26:253–267CrossRefGoogle Scholar
  10. 10.
    Mandas A, Congiu MG, Balestrieri C et al (2008) Nutritional status and oxidative stress in an elderly Sardinian population. Mediterr J Nutr Metab 1:99–107CrossRefGoogle Scholar
  11. 11.
    Mantovani G, Maccio A, Madeddu C et al (2003) The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression. Free Radic Res 37:213–223CrossRefGoogle Scholar
  12. 12.
    Jakab F, Shoenfeld Y, Balogh A et al (2003) A medical nutriment has supportive value in the treatment of colorectal cancer. Br J Cancer 89:465–469CrossRefGoogle Scholar
  13. 13.
    Spitzer WO, Dobson AJ, Hall J et al (1981) Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Cron Dis 34:585–597CrossRefGoogle Scholar
  14. 14.
    Ivkovic S, Zabcic D (2002) The effect of tribomechanically activated zeolite (TMAZ) on total antioxidant status of healthy individuals and patients with malignant disease. Free Radic Biol Med 33[Suppl 1]Google Scholar
  15. 15.
    Martarelli D, Pompei P (2009) Oxidative stress and antioxidant changes during a 24-hours mountain bike endurance exercise in master athletes. J Sports Med Phys Fitness 49:122–127Google Scholar
  16. 16.
    Vassalle C (2008) An easy and reliable automated method to estimate oxidative stress in the clinical setting. Methods Mol Biol 477:31–39CrossRefGoogle Scholar
  17. 17.
    Stringer AM, Gibson RJ, Bowen JM et al (2007) Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment. J Support Oncol 5:259–267Google Scholar
  18. 18.
    Wang J, Lu Z, Au JL (2006) Protection against chemotherapy-induced alopecia. Pharm Res 23:2505–2514CrossRefGoogle Scholar
  19. 19.
    Buijs C, de Vries EG, Mourits MJ, Willemse PH (2008) The influence of endocrine treatments for breast cancer on health-related quality of life. Cancer Treat Rev 34:640–655CrossRefGoogle Scholar
  20. 20.
    Trotti R, Carratelli M, Barbieri M (2002) Performance and clinical application of a new, fast method for the detection of hydro-peroxides in serum. Panminerva Med 44:37–40Google Scholar
  21. 21.
    Kusmic C, Petersen C, Picano E et al (2000) Antioxidant effect of oral dipyramidole during cerebral hypoperfusion with human carotid endarterectomy. J Cardiovasc Pharmacol 36:141–145CrossRefGoogle Scholar
  22. 22.
    Cornelli U, Terranova R, Luca S et al (2001) Bioavailability of some food supplementations in men and women using the d-ROMs test as a marker of oxidative stress. J Nutr 131:3208–3211Google Scholar
  23. 23.
    Fracchiolla NS, Guggiari E, Maissonneuve P et al (2001) Oxidative stress in myelodysplastic syndromes: increased levels of reactive oxygen metabolites and homocysteine. Blood 98:271bGoogle Scholar
  24. 24.
    Gerardi GM, Usberti M, Martini G et al (2002) Plasma total antioxidant capacity in hemodialyzed patients and its relationship to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 40:104–110CrossRefGoogle Scholar
  25. 25.
    Belcaro G, Cesarone MR, Nicolaides AN et al (2003) Improvement of microcirculation and healing of venous hypertension and ulcers with Crystacide. Evaluation of free radicals, laser Doppler flux and pO2. A prospective-randomized-controlled study. Angiology 54:325–330CrossRefGoogle Scholar
  26. 26.
    Flore R, Gerardino L, Santoliquido A et al (2004) Enhanced oxidative stress in workers with a standing occupation. Occup Environ Med 61:548–550CrossRefGoogle Scholar
  27. 27.
    Vassalle C, Boni C, Di Cecco P, Landi P (2005) Elevated hydro-peroxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease. Int J Cardiol 110:415–416CrossRefGoogle Scholar
  28. 28.
    Komatsu F, Kagawa Y, Sakuma M et al (2006) Investigation of oxidative stress and dietary habits in Mongolian people, compared to Japanese people. Nutr Metab 3:21–39CrossRefGoogle Scholar
  29. 29.
    Ladas EJ, Jacobson JS, Kennedy DD et al (2004) Antioxidants and cancer therapy: a systematic review. J Clin Oncol 22:517–528CrossRefGoogle Scholar
  30. 30.
    Corsi MM, Pagani D, Iorio EL et al (2006) Blood reactive oxygen metabolites (ROMs) and total antioxidant status (TAS) in patients with laryngeal squamous cell carcinoma after surgical treatment. Clin Chem Lab Med 44:1047–1048CrossRefGoogle Scholar
  31. 31.
    La Torre F, Orlando A, Silipigni A et al (1996) Increase of oxygen free radicals and their derivatives in chemo- and radiation treated neoplastic patients. Minerva Med 86:1–4Google Scholar
  32. 32.
    Grey V, Mohammed SR, Smountas AA et al (2003) Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros 2:195–198CrossRefGoogle Scholar
  33. 33.
    Lands LC, Grey VL, Smountas AA (1999) Effect of supplementation with a cysteine donor on muscular performance. J Appl Physiol 87:1381–1385Google Scholar
  34. 34.
    Li Y, Schellhorn HE (2007) New developments and novel therapeutic perspectives for vitamin C. J Nutr 137:2171–2184Google Scholar
  35. 35.
    Droge W (2005) Oxidative stress and ageing: is ageing a cysteine deficiency syndrome? Philos Trans R Soc Lond B Biol Sci 360:2355–2372CrossRefGoogle Scholar
  36. 36.
    Mieyal JJ, Gallogly MM, Qanungo S et al (2008) Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 10:1941–1988CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • G. Landoni
    • 1
    • 2
  • E. Mariani
    • 1
    • 2
  • G. Oriani
    • 1
    • 2
  • C. Donarini
    • 1
    • 2
  • T. Guerrerio
    • 1
  • E.L. Iorio
    • 3
  1. 1.Istituto Clinico S. SiroMilanItaly
  2. 2.Società Italiana di Medicina AntroposoficaMilanItaly
  3. 3.International Observatory of Oxidative StressVia Paolo Grisignano 21SalernoItaly

Personalised recommendations